Guardant Health to Showcase New Data at San Antonio Breast Cancer Symposium 2022 Demonstrating Utility of Its Blood Tests for Advanced-stage Breast Cancer Patients

(marketscreener.com) Presentations to highlight role of Guardant liquid biopsy tests and real-world data to help identify actionable biomarkers, co-occurring mutations and molecular response to therapyhttps://www.marketscreener.com/quote/stock/GUARDANT-HEALTH-INC-46434671/news/Guardant-Health-to-Showcase-New-Data-at-San-Antonio-Breast-Cancer-Symposium-2022-Demonstrating-Utili-42453460/?utm_medium=RSS&utm_content=20221201